225 related articles for article (PubMed ID: 13367321)
1. The relative merits of prostigmin and mestinon in the treatment of myasthenia gravis.
GUINENA YH; NABI SA; TAHER Y
J Egypt Med Assoc; 1956 Jun; 39(3):240-51. PubMed ID: 13367321
[No Abstract] [Full Text] [Related]
2. Treatment of myasthenia gravis; prolonged action with multiple-dose tablets of neostigmine bromide and mestinon bromide.
SCHWAB RS; OSSERMAN KE; TETHER JE
J Am Med Assoc; 1957 Oct; 165(6):671-4. PubMed ID: 13462827
[No Abstract] [Full Text] [Related]
3. [Treatment of myasthenia gravis with pyridostigmine (mestinon)].
BARRAQUER-BORDAS L; PONCESVERGE J
Rev Clin Esp; 1955 Aug; 58(4):236-43. PubMed ID: 13281050
[No Abstract] [Full Text] [Related]
4. Mestinon (pyridostigmine bromide) in myasthenia gravis.
SCHWARZ H
Can Med Assoc J; 1956 Jul; 75(2):98-100. PubMed ID: 13343058
[No Abstract] [Full Text] [Related]
5. Pyridostigmine (mestinon) in myasthenia gravis; a case report.
POLLITZER RS
J S C Med Assoc; 1956 Feb; 52(2):46-7. PubMed ID: 13286785
[No Abstract] [Full Text] [Related]
6. Mestinon in the treatment of myasthenia gravis.
WESTERBERG MR; MAGEE KR
Neurology; 1954 Oct; 4(10):762-72. PubMed ID: 13214277
[No Abstract] [Full Text] [Related]
7. [Mestinon, a new remedy for myasthenia gravis].
LONNUM A
Tidsskr Nor Laegeforen; 1955 Aug; 75(16):581-2. PubMed ID: 13267868
[No Abstract] [Full Text] [Related]
8. Treatment of myasthenia gravis with mestinon bromide.
TETHER JE
J Am Med Assoc; 1956 Jan; 160(3):156-8. PubMed ID: 13278161
[No Abstract] [Full Text] [Related]
9. Treatment of myasthenia gravis with prolonged-action mestinon.
MAGEE KR; WESTERBERG MR
Neurology; 1959 May; 9(5):348-51. PubMed ID: 13657293
[No Abstract] [Full Text] [Related]
10. Studies in myasthenia gravis; preliminary report on therapy with mestinon bromide.
OSSERMAN KE; TENG P; KAPLAN LI
J Am Med Assoc; 1954 Jul; 155(11):961-5. PubMed ID: 13162833
[No Abstract] [Full Text] [Related]
11. [Initial experiments with pyridostigmine (mestinon Roche)].
RADERMECKER MA
Acta Neurol Psychiatr Belg; 1955 Apr; 55(4):356-63. PubMed ID: 13248495
[No Abstract] [Full Text] [Related]
12. Progress report on mestinon bromide (pyridostigmine bromide).
OSSERMAN KE
Am J Med; 1955 Nov; 19(5):737-9. PubMed ID: 13268474
[No Abstract] [Full Text] [Related]
13. Report of a case of myasthenia gravis.
BRYAN FA
J Indiana State Med Assoc; 1956 Mar; 49(3):257-8. PubMed ID: 13306994
[No Abstract] [Full Text] [Related]
14. MYASTHENIA gravis.
Br Med J; 1956 Jun; 1(4978):1283-4. PubMed ID: 13316135
[No Abstract] [Full Text] [Related]
15. Advantages of pyridostigmine bromide (mestinon) and edrophonium chloride (tensilon) in the treatment of transitory myasthenia gravis in the neonatal period.
MOORE H
N Engl J Med; 1955 Dec; 253(24):1075-6. PubMed ID: 13272842
[No Abstract] [Full Text] [Related]
16. [Case of myasthenia gravis].
KATILA O; KIVALO E
Duodecim; 1955; 71(4):605-10. PubMed ID: 14391241
[No Abstract] [Full Text] [Related]
17. Urecholine in myasthenia gravis.
SCHWARZ H
Can Med Assoc J; 1955 Mar; 72(5):346-51. PubMed ID: 14352096
[No Abstract] [Full Text] [Related]
18. [Blood cholinesterase during the treatment of myasthenia by anti-cholinesterase drugs (prostigmine and mestinon)].
VINCENT D; PLANQUES J; GERAUD J; DARDENNE P
Therapie; 1960; 15():906-13. PubMed ID: 13781449
[No Abstract] [Full Text] [Related]
19. Pyridostigmin (mestinon) in the treatment of myasthenia gravis.
SCHWAB RS; TIMBERLAKE WH
N Engl J Med; 1954 Aug; 251(7):271-2. PubMed ID: 13185412
[No Abstract] [Full Text] [Related]
20. Tiopronin-induced myasthenia.
Cherasse A; Maillefert JF; Henlin JL; Chassard D; Tavernier C
Rev Rhum Engl Ed; 1999 Apr; 66(4):238-9. PubMed ID: 10339785
[No Abstract] [Full Text] [Related]
[Next] [New Search]
